NCT05072093CompletedPhase 4
Parrying the Pitfalls of PrEP: Project PEACH
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs Among MSM
Source: ClinicalTrials.gov · Last updated 1 Apr 2026
Brief summary (registry, in English)
The study is a prospective cohort of young MSM who are followed for 2 years either in-person at the PRISM Health Research Clinic and/or virtually with telehealth study visits. Follow-up visits occur as frequently as every 3 months, or as appropriate to clinical needs of HIV PrEP or STI PEP. The investigators will enroll men who may decide to start or stop PrEP, change from daily oral PrEP to on-demand oral PrEP or from on-demand oral PrEP to daily PrEP, to start or stop STI PEP at any point in the study period, or injectable PrEP as an alternative to daily oral PrEP or on-demand oral PrEP. All men will be provided with the study's mobile smart phone app to support early identification of risks for PrEP discontinuation, to provide information about STI PEP and document usage patterns of on-demand oral PrEP and STI PEP, and to support easy linkage to support services for PrEP counseling and addressing concerns or questions about STI PEP and injectable PrEP.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 240 (actual)
- First submitted
- 28 Sept 2021
- Start date
- 20 Nov 2021
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- Emory University
- Diseases
- HIV
- NCT number
- NCT05072093
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 240
- From 20 Nov 2021 to the primary completion date, 31 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No male anal sex partner in the 12 months before the baseline interview
Other illness
- HIV positive status
- Currently enrolled in an HIV prevention or treatment clinical trial
Age
- Individuals \< 18 years of age or \> 45 years of age
Other
- Female at birth
- Do not self-identify as Cisgender Male
- Does not own mobile phone with data service
- Not willing to download a health-related app to their cell phone as part of the research study
- Live outside the metro Atlanta MSA and/or planning to move from Atlanta area in the next 2 years
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Who the study is looking for
- Male at birth
- Self-identify as Cisgender Male
- Ages 18-45 years
- ≥1 male anal sex partner in the 12 months before the baseline interview
- Live in the Atlanta MSA
- Owns cell phone with data service
- Willing to download a health-related app to their cell phone as part of the research study
- Able to provide ≥ 2 means of contact
- Not currently enrolled in another HIV prevention clinical trial
- Confirmed HIV-negative at baseline visit
Age in the registry: 18 years to 45 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PRISM Research Center Coordinator of this site? Confirm its status | Atlanta | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.